Skip to content
★ Sign in to follow
WL

Walter Lloyd Sanders

Myriad Genetics IncGenta Inc de/
Total declarations
13
Companies
2
▲ Purchases (4 ops.)
€15k
▼ Sales (2 ops.)
€39k

Latest filing published 02 Oct 2018 for Myriad Genetics INC, €25k.

Insider track record

Disclosed buys
4
Disclosed sells
2
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Walter Lloyd Sanders: trading record in brief

Walter Lloyd Sanders discloses dealings in 2 companies, chiefly Genta Inc de/ and Myriad Genetics Inc. We count 13 filings; the first trade dates from 15 June 2006 and the latest from 30 September 2018.

On the open market, the record shows 4 purchases worth €15k and 2 sales worth €39k. Taken together, the sales exceed the purchases by €24k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant.

A typical purchase (the median) is worth €346.

The newest entry dates from 2 October 2018: a transaction of €25k, in Myriad Genetics Inc. The latest purchase dates back some time: it was published 7,299 days ago, on 15 November 2006. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Walter Lloyd Sanders

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ●
    President Myriad OncologyExecutivesMyriad Genetics Inc
    28,934 USD24SEC
    629 shares@ US$46.0020.0% of flowCommon StockSEC:0001349943-18-000012:0
  • ●
    President Myriad OncologyExecutivesMyriad Genetics Inc
    77,626 USD27SEC
    1,664 shares@ US$46.6553.0% of flowCommon StockSEC:0001349943-18-000010:0
  • ●
    President Myriad OncologyExecutivesMyriad Genetics Inc
    39,119 USD25SEC
    844 shares@ US$46.3526.9% of flowCommon StockSEC:0001349943-18-000008:0
  • ▼
    Chief Operating OfficerExecutivesGenta Inc de/
    16,932 USD0SEC
    102,000 shares@ US$0.166Common StockSEC:0001140361-09-027572:0
  • ▼
    Chief Operating OfficerExecutivesGenta Inc de/
    41,450 USD0SEC
    265,704 shares@ US$0.156Common StockSEC:0001140361-09-027572:1
  • ◆
    Senior VP, Chief Operating OffExecutivesGenta Inc de/
    0SEC
    4,412,446 sharesCommon StockSEC:0001140361-09-020728:0
  • ●
    Senior VP & COOExecutivesGenta Inc de/
    0SEC
    53 shares0Common Stock, par value $.001SEC:0001005477-08-002919:0
  • ●
    Senior VP & COOExecutivesGenta Inc de/
    0SEC
    51 shares0Common stock, par value $.001SEC:0001005477-08-002919:1
  • ▲
    VP, Sales & MarketingExecutivesGenta Inc de/
    18,750 USD0SEC
    25,000 shares@ US$0.75Common Stock, par value $.001SEC:0001005477-06-005448:0
    Canonical exit: 13 Feb 2007 (T+90)
  • ▲
    VP, Sales & MarketingExecutivesGenta Inc de/
    91 USD0SEC
    56 shares@ US$1.63Common Stock, par value $.001SEC:0001005477-06-003255:0
    Canonical exit: 21 Sept 2006 (T+90)
  • ▲
    VP, Sales & MarketingExecutivesGenta Inc de/
    486 USD0SEC
    322 shares@ US$1.51Common Stock, par value $.001SEC:0001193805-06-001574:0
    Canonical exit: 13 Sept 2006 (T+90)
  • ▲
    VP, Sales & MarketingExecutivesGenta Inc de/
    388 USD0SEC
    255 shares@ US$1.52Common Stock, par value $.001SEC:0001193805-06-001574:1
    Canonical exit: 13 Sept 2006 (T+90)

12 of 12 declarations